(MedPage Today) — With spironolactone (Aldactone) treatment for acne rising several-fold in recent decades, safety concerns persist for this off-label practice in understudied populations.
A database of U.S. insurance claims showed that among…
Source link : https://www.medpagetoday.com/dermatology/generaldermatology/114693
Author :
Publish date : 2025-03-17 19:35:00
Copyright for syndicated content belongs to the linked Source.
